Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05135403 · ClinicalTrials.gov registry record

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

A clinical trial of Sudden Cardiac Arrest, sponsored by Kestra Medical Technologies.

Recruiting
Registry status
5,179
Enrollment target
1
Study location

NCT05135403 is a study of Sudden Cardiac Arrest that is actively recruiting participants, run by Kestra Medical Technologies. The registered enrollment target is 5,179 participants, above the 1,187-participant average among 8 other Sudden Cardiac Arrest trials with a reported enrollment target (336% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05135403, a study of Sudden Cardiac Arrest, is actively recruiting participants, sponsored by Kestra Medical Technologies.

RECRUITING
Registry status
5,179 participants
Enrollment target
1
Study location

Study Summary

Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.

Conditions Studied

Interventions

  • DEVICE Defibrillation

Study Locations (1)

Washington

  • University of Washington Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 5,179 participants
Start Date 2021-11-20
Est. Completion 2025-10-01

Sponsor

Kestra Medical Technologies

3 total trials

What the Registry Record Tells You About NCT05135403

The ClinicalTrials.gov registry entry for NCT05135403 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,179 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,187-participant average among 8 other Sudden Cardiac Arrest trials with a reported enrollment target (336% higher). The listed sponsor is Kestra Medical Technologies, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sudden Cardiac Arrest appearing as the primary indexed condition, and to 1 intervention - of which Defibrillation is the first listed.

NCT05135403 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05135403 about?

NCT05135403 is a clinical study titled "ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)". Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.

What is the current status of trial NCT05135403?

This trial is currently recruiting. The enrollment target is 5,179 participants. The study started on 2021-11-20. Estimated completion is 2025-10-01.

What conditions does trial NCT05135403 study?

This clinical trial studies the following conditions: Sudden Cardiac Arrest.

What interventions are being tested in trial NCT05135403?

The interventions under investigation include: Defibrillation (DEVICE).

Who is sponsoring clinical trial NCT05135403?

This trial is sponsored by Kestra Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05135403 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sudden Cardiac Arrest

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.